Skip to main content
. 2022 Aug 18;41(2):233–242. doi: 10.1200/JCO.22.00184

FIG 1.

FIG 1.

Flow diagram of 58 patients enrolled in the study. aRepresents ypT, cN0 stage. bRepresents yp stage. c, clinical; CAPOX, capecitabine-oxaliplatin; mFOLFOX, modified folinic acid–flurouracil-oxaliplatin 6; N, node; oOPR, observed organ preservation rate; psOPR, protocol-specified organ preservation rate; T, tumor; TES, transanal excision surgery; TME, total mesorectal excision; yp, pathologic stage following systemic or radiation therapy prior to surgery.